A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes

Author： Seidlitz Eric P.   Sharma Mohit K.   Singh Gurmit  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.88, Iss.3, 2010-03, pp. : 197-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disruption of Metabolic Pathways - Perspectives for the Treatment of Cancer

By  

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 77-87

Bentham Science Publishers

Access to resources Recommend Favorite

Depo-Provera may cause loss of bone mineral density

By  

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

HT-related decrease in breast density may cause breast cancer

By  

Reactions Weekly, Vol. 1, Iss. 1151, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin

By  

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. : 226-235

Bentham Science Publishers

Access to resources Recommend Favorite

Adipocytokines; Cause for Metabolic Syndrome

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 2, 2003-06 ,pp. : 121-125

Bentham Science Publishers

Access to resources Recommend Favorite